Premium
Gamot API-operated active pharma ingredient platform Sekhmet Pharmaventures is in the fray with Ahmedabad-based Nirma Group for acquisition of Glenmark Pharma’s subsidiary, said a media report, citing several people aware of the development. Sekhmet, backed by the likes of PAG, CX Partners and Samara Capital is also likely to have ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.